Farther Finance Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
GA
MCP
EIA
EB
NFGCM
BFA
HWA
VFA
RI
BSB
Farther Finance Advisors's NVO Position: Q3 2026 in Review
Farther Finance Advisors increased its Novo Nordisk (NVO) stake by 11% in Q3 2026, buying an estimated $406K and bringing the position to 91,827 shares worth $3.48M. The position accounts for 0.02% of the portfolio, ranked #549.
Farther Finance Advisors first reported a position in NVO in Q4 2022 and has held it in 16 quarters since. The position peaked at $7.12M in Q2 2025. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Farther Finance Advisors held 91,827 shares of Novo Nordisk worth $3.48M as of Q3 2026.
- Farther Finance Advisors bought 8,807 Novo Nordisk shares in Q3 2026, an estimated $406K.
- Novo Nordisk made up 0.02% of Farther Finance Advisors's portfolio in Q3 2026, its #549 holding.
- Farther Finance Advisors first reported a position in Novo Nordisk in Q4 2022 and has held it in 16 quarters since.
- Farther Finance Advisors's Novo Nordisk position peaked at $7.12M in Q2 2025.
- 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.